CRISPR/Cas9 in Gastrointestinal Malignancies
Gastrointestinal (GI) cancers such as colorectal cancer (CRC), gastric cancer (GC), esophageal cancer (EG), pancreatic duct adenocarcinoma (PDAC) or hepatocellular cancer (HCC) belong to the most commonly diagnosed types of cancer and are among the most frequent causes of cancer related death worldw...
Guardado en:
Autores principales: | André Jefremow, Markus F. Neurath, Maximilian J. Waldner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc1eb513e2c442008558bd7c5c86998e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer
por: Tiruneh G/Medhin M, et al.
Publicado: (2021) -
Physical Activity and Gastrointestinal Cancer Risk: A Review
por: Tajabadi Z., et al.
Publicado: (2019) -
Scope of Artificial Intelligence in Gastrointestinal Oncology
por: Hemant Goyal, et al.
Publicado: (2021) -
CRISPR and KRAS: a match yet to be made
por: Guzide Bender, et al.
Publicado: (2021) -
Characterization of a Type II-A CRISPR-Cas System in <italic toggle="yes">Streptococcus mutans</italic>
por: Cas Mosterd, et al.
Publicado: (2020)